Local treatment of Dacron patch graft contaminated with Staphylococcus aureus with antibiotic-releasing porous apatite ceramic: an experimental study in the rabbit.

OBJECTIVE The purpose of this study was to investigate whether or not infection of prosthetic vascular graft could be prevented with the placement of antibiotic-loaded porous apatite ceramic on the graft with bacterial contamination. METHODS Teicoplanin as an antibiotic was loaded into a beta-tricalcium phosphate (TCP) block of porous apatite ceramic. The activity of teicoplanin released from teicoplanin-loaded TCP was examined for 40 days at 2-day intervals. In an in vivo study, the graft was patched in the abdominal aorta of a rabbit. Two different doses of Staphylococcus aureus were applied (n = 13). Teicoplanin-loaded TCP was placed around the graft infected with S aureus (n = 6). The graft, the tissue around it, and the arterial blood were collected and cultivated 4 weeks after operation. RESULTS The activity of teicoplanin in the replaced saline solution was maintained for at least 40 days. Because graft infection was established in all rabbits with a dose of 2 x 10(7) colony forming units, this dose was used as the dose of S aureus in this study. Fifty-seven percent of the subjects died from the infection. When teicoplanin-loaded TCP was placed around the graft contaminated with S aureus, no rabbits died. Bacterial cultures of the graft and of tissues around it were negative in all rabbits killed 4 weeks after operation. This infection was prevented with teicoplanin-loaded TCP in all rabbits. CONCLUSION Teicoplanin-loaded TCP may be useful in avoiding Dacron graft infection with S aureus in rabbits.

[1]  N. Azuma,et al.  Limitations in the use of rifampicin-gelatin grafts against virulent organisms. , 2002, Journal of vascular surgery.

[2]  Seeger Jm.  Management of patients with prosthetic vascular graft infection. , 2000 .

[3]  T. Huber,et al.  Influence of Patient Characteristics and Treatment Options on Outcome of Patients with Prosthetic Aortic Graft Infection , 1999, Annals of vascular surgery.

[4]  J. Thompson,et al.  Gentamicin beads in vascular surgery: long-term results of implantation. , 1999, Cardiovascular surgery.

[5]  J. Holdsworth.  Treatment of infective and potentially infective complications of vascular bypass grafting using gentamicin with collagen sponge. , 1999, Annals of the Royal College of Surgeons of England.

[6]  Y. Katagiri,et al.  Development of porous apatite ceramic for local delivery of chemotherapeutic agents. , 1998, Journal of biomedical materials research.

[7]  S. Wilson,et al.  Local treatment of prosthetic vascular graft infection with multivesicular liposome-encapsulated amikacin. , 1998, The Journal of surgical research.

[8]  K. Watanabe,et al.  Antibiotic-loaded hydroxyapatite blocks in the treatment of experimental osteomyelitis in rats. , 1997, Journal of medical microbiology.

[9]  M. Fishbein,et al.  Sustained local drug delivery to the arterial wall via biodegradable microspheres. , 1997, Catheterization and Cardiovascular Diagnosis.

[10]  M. Wood,et al.  The comparative efficacy and safety of teicoplanin and vancomycin. , 1996, The Journal of antimicrobial chemotherapy.

[11]  M. Bubrick,et al.  The use of biodegradable amikacin microspheres to prevent vascular graft infection. , 1994, The Journal of surgical research.

[12]  M. Oka,et al.  Treatment of osteomyelitis by antibiotic impregnated porous hydroxyapatite block. , 1994, Clinical materials.

[13]  F. Tenover,et al.  Accuracy of the E test for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobacter jejuni, and gram-negative bacteria resistant to antimicrobial agents , 1992, Journal of clinical microbiology.

[14]  P. Massip,et al.  Local antibiotic prophylaxis in inguinal hernia repair. , 1992, Surgery, gynecology & obstetrics.

[15]  H. Gelabert,et al.  Use of an antibiotic-bonded graft for in situ reconstruction after prosthetic graft infections. , 1992, Journal of vascular surgery.

[16]  L. V. von Segesser,et al.  Implantation of antibiotic-releasing carriers and in situ reconstruction for treatment of mycotic aneurysm. , 1992, Archives of surgery.

[17]  O. Nielsen,et al.  Gentamycin beads in the treatment of localised vascular graft infection--long term results in 17 cases. , 1991, European journal of vascular surgery.

[18]  D. Bandyk,et al.  Antibiotic-bonded PTFE vascular grafts: the effect of silver antibiotic on bioactivity following implantation. , 1991, The Journal of surgical research.

[19]  J. Lorentzen,et al.  Clinical and pharmacokinetic evaluation of gentamycin containing collagen in groin wound infections after vascular reconstruction. , 1991, European journal of vascular surgery.

[20]  A. Corti,et al.  Comparison of the solid phase enzyme receptor assay (SPERA) and the microbiological assay for teicoplanin. , 1986, The Journal of hospital infection.

[21]  N. Fiddian,et al.  Ruptured femoral vein. A complication of the use of gentamicin beads in an infected excision arthroplasty of the hip. , 1984, The Journal of bone and joint surgery. British volume.

[22]  H. Polk,et al.  Combined topical and systemic antibiotic prophylaxis in experimental wound infection. , 1984, American journal of surgery.

[23]  H. Pitt,et al.  Prophylactic Antibiotics in Vascular Surgery: Topical, Systemic, or Both? , 1980, Annals of surgery.

[24]  J. Brady,et al.  Reaction of bone to tricalcium phosphate ceramic pellets. , 1972, Oral surgery, oral medicine, and oral pathology.

[25]  J M Brady,et al.  Biodegradable ceramic implants in bone. Electron and light microscopic analysis. , 1971, Oral surgery, oral medicine, and oral pathology.

[26]  J. A. Webb,et al.  Primary tumors of the heart: results of surgical treatment in ten patients. , 1966, The Journal of cardiovascular surgery.